This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Tuesday's ETF Winners & Losers

Health care-related exchange-traded funds were among the top performers of Tuesday's session, thanks to an upswing in several biotech and medical device manufacturer stocks.

The Biotech HOLDRs (BBH) was higher by 1.1%. Among its holdings, Genentech (DNA) was rising 2.3%, Amgen (AMGN) gained 1.4%, and Gilead Sciences (GILD) tacked on 1%.

Recently, the Biotech HOLDRs was higher by $2.12 to $189.27.

The iShares Dow Jones U.S. Medical Devices (IHI) was also higher, thanks to gains of 2% or more in holdings St. Jude Medical (STJ), Boston Scientific (BSX) and Medtronic (MDT).

The ETF was gaining 41 cents, or 0.8%, to $54.87.

On the losing side, the Internet Infrastructure HOLDRs (IIH) slid more than 2%. Among its holdings, BEA Systems (BEAS) was slumping 3.8%, Akamai Technologies (AKAM) was losing 2.6%, and VeriSign (VRSN) was down 1.9%.

The Internet Infrastructure HOLDRs ETF was recently falling 11 cents, or 2.2%, to $4.97.

Other Internet names were suffering. Ariba (ARBA) fell 2.3%, and Checkfree (CKFR) was shedding 0.5%. Both holdings combined to sink the B2B Internet HOLDRs (BHH), which was recently down 3 cents, or 1.5%, to $2.

ETFs tracking silver and gold were also lower. Silver futures dropped 20 cents to $13.37 an ounce. Gold futures lost $6.20 to close at $677.30 an ounce

The iShares Silver Trust (SLV) was shedding 1.4% to $131.45. The Market Vectors Gold Miners (GDX) eased 1.2% to $39.09. The PowerShares DB Silver (DBS) ETF was recently down 1.2% to $26.09. The streetTRACKS Gold Shares (GLD) ETF was off 0.6% to $66.71.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,106.70 +29.83 0.17%
S&P 500 2,000.02 +2.10 0.11%
NASDAQ 4,570.6370 +13.29 0.29%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs